Health ❯ Public Health ❯ Disease Prevention

COVID-19

Testing Testing and Vaccination CDC Guidelines Update High-Risk Populations Health Advisory Homeless Population Organ-specific Diseases Health Services Post-Exposure Prophylaxis Vaccination Strategies COVID-19 Guidelines Immunity Variants of COVID-19 Vaccination Efficacy Long COVID

FDA Approves Xocova as First U.S. Post-Exposure COVID-19 Antiviral

This provides an oral post-exposure tool meant to reduce household spread when started within 72 hours of exposure.

Large Trial Finds No Acute COVID Benefit From Vitamin D, Hints at Fewer Long COVID Symptoms

FDA Approves Moderna’s mNEXSPIKE for Seniors and High-Risk Adults as CDC Drops Recommendations for Healthy Children and Pregnant Women